Loading clinical trials...
Loading clinical trials...
A Phase II, Single Arm Study of Atezolizumab + Bevacizumab in Women With Advanced, Recurrent or Persistent Endometrial Cancer
Conditions
Interventions
Bevacizumab
Atezolizumab
Locations
3
United States
UAB Women and Infants Center
Birmingham, Alabama, United States
Washington University School of Medicine
St Louis, Missouri, United States
Stephenson Cancer Center, University of Oklahoma Health Sciences Center
Oklahoma City, Oklahoma, United States
Start Date
August 8, 2018
Primary Completion Date
March 31, 2026
Completion Date
September 1, 2026
Last Updated
October 24, 2025
NCT05489211
NCT04657068
NCT04585750
NCT07029399
NCT06975293
NCT07166094
Lead Sponsor
University of Oklahoma
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions